{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:09Z","timestamp":1791475449743,"version":"4.3.4"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Growth hormone (GH) deficiency is a common pituitary hormone deficiency in childhood cancer survivors (CCS). The identification, diagnosis, and treatment of those individuals at risk are important in order to minimize associated morbidities that can be ameliorated by treatment with recombinant human GH therapy. However, GH and insulin-like growth factor-I have been implicated in tumorigenesis, so there has been concern over the use of GH therapy in patients with a history of malignancy. Reassuringly, GH therapy has not been shown to increase risk of tumor recurrence. These patients have an increased risk for development of meningiomas, but this may be related to their history of cranial irradiation rather than to GH therapy. In this review, we detail the CCS who are at risk for GHD and the existing evidence on the safety profile of GH therapy in this patient population.<\/jats:p>","DOI":"10.3389\/fendo.2021.745932","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T07:08:47Z","timestamp":1634886527000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors"],"prefix":"10.3389","volume":"12","author":[{"given":"Netanya I.","family":"Pollock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5025","article-title":"Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study","volume":"34","author":"Clement","year":"2016","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1159\/000452150","article-title":"Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency","volume":"86","author":"Grimberg","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01205","article-title":"GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198611000-00038","article-title":"Effect of Spinal Irradiation on Growth","volume":"20","author":"Shalet","year":"1986","journal-title":"Pediatr Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa478","article-title":"Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation","volume":"105","author":"Rose","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0832","article-title":"The Characteristics of Quality of Life Impairment in Adult Growth Hormone (GH)-Deficient Survivors of Cancer and Their Response to GH Replacement Therapy","volume":"90","author":"Mukherjee","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0178","article-title":"Long-Term Safety of Recombinant Human Growth Hormone in Children","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2046","article-title":"Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study","volume":"102","author":"Swerdlow","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13131","article-title":"Mortality and Cancer Incidence Among Patients Treated With Recombinant Growth Hormone During Childhood in Israel","volume":"85","author":"Libruder","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13502","article-title":"Long-Term Safety of Growth Hormone\u2014A Combined Registry Analysis","volume":"88","author":"Stochholm","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth Hormone, the Insulin-Like Growth Factor Axis, Insulin and Cancer Risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1989.tb01721.x","article-title":"Risk Factors for Leukemia Occurrence Among Growth Hormone Users","volume":"80","author":"Watanabe","year":"1989","journal-title":"Japanese J Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09519-3","article-title":"Risk of Cancer in Patients Treated With Human Pituitary Growth Hormone in the UK, 1959-85: A Cohort Study","volume":"360","author":"Swerdlow","year":"2002","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91968-X","article-title":"Leukaemia in Patients Treated With Growth Hormone","volume":"331","author":"Watanabe","year":"1988","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1995","article-title":"Long-Term Mortality After Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study","volume":"97","author":"Carel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2882","article-title":"Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated With Recombinant Growth Hormone During Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study","volume":"97","author":"S\u00e4vendahl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11102-008-0088-4","article-title":"Hypopituitarism Following Radiotherapy","volume":"12","author":"Darzy","year":"2009","journal-title":"Pituitary"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1988.02150080053022","article-title":"Effects of Low-Dose Cranial Radiation on Growth Hormone Secretory Dynamics and Hypothalamic-Pituitary Function","volume":"142","author":"Costin","year":"1988","journal-title":"Am J Dis Child"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/adc.64.2.252","article-title":"Suppressed Spontaneous Secretion of Growth Hormone in Girls After Treatment for Acute Lymphoblastic Leukemia","volume":"64","author":"Moell","year":"1989","journal-title":"Arch Dis Child"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2599","article-title":"Cranial Irradiation and Growth Hormone Neurosecretory Dysfunction: A Critical Appraisal","volume":"92","author":"Darzy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01204","article-title":"Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers","volume":"103","author":"Sfeir","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.2.0329","article-title":"The Diagnosis of Growth Hormone Deficiency in Children and Adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-014-2406-3","article-title":"Diagnostic Value of Serum IGF-1 and IGFBP-3 in Growth Hormone Deficiency: A Systematic Review With Meta-Analysis","volume":"174","author":"Shen","year":"2015","journal-title":"Eur J Pediatr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.2.531","article-title":"Biochemical Tests in the Diagnosis of Childhood Growth Hormone Deficiency","volume":"82","author":"Tillmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000023237","article-title":"Serum Insulin-Like Growth Factor-I, IGF Binding Protein-3 and IGFBP-3 Protease Activity After Cranial Irradiation","volume":"50","author":"Tillman","year":"1998","journal-title":"Horm Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00585.x","article-title":"The Relationship Between the Growth Hormone and Insulin-Like Growth Factor Axis in Long-Term Survivors of Childhood Brain Tumours","volume":"49","author":"Achermann","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000495760","article-title":"The Predictive Value of Insulin-Like Growth Factor 1 in Irradiation-Dependent Growth Hormone Deficiency in Childhood Cancer Survivors","volume":"90","author":"Cattoni","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00804.x","article-title":"Serum IGF-I and IGFBP-3 Concentrations do Not Accurately Predict Growth Hormone Deficiency in Children With Brain Tumours","volume":"51","author":"Weinzimer","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80487-1","article-title":"Dose Dependency of Time of Onset of Radiation-Induced Growth Hormone Deficiency","volume":"118","author":"Clayton","year":"1991","journal-title":"J Pediatr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.17.S4.1","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly\u20132011 Update","volume":"17","author":"Katznelson","year":"2011","journal-title":"Endocr Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0509","article-title":"Mortality in Acromegaly Decreased in the Last Decade: A Systematic Review and Meta-Analysis","volume":"181","author":"Bolfi","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0178","article-title":"Acromegaly and Cancer: An Old Debate Revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00166","article-title":"Growth Hormone\u2019s Links to Cancer","volume":"40","author":"Boguszewski","year":"2019","journal-title":"Endocr Rev"},{"key":"B34","first-page":"297","article-title":"Neoplasms in Rats Treated With Pituitary Growth Hormone I. Pulmonary and Lymphatic Tissues","volume-title":"Cancer Res","author":"Moon","year":"1950"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgl138","article-title":"Inhibition of Estrogen-Independent Mammary Carcinogenesis by Disruption of Growth Hormone Signaling","volume":"28","author":"Zhang","year":"2007","journal-title":"Carcinogenesis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000186","article-title":"Growth Hormone in the Tumor Microenvironment","volume":"63","author":"Chesnokova","year":"2019","journal-title":"Arch Eof ndocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1984.tb01385.x","article-title":"Hypothalamic Growth Hormone Releasing Factor Deficiency Following Cranial Irradiation","volume":"21","author":"Ahmed","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02525.x","article-title":"Radiation and Neuroregulatory Control of Growth Hormone Secretion","volume":"41","author":"Ogilvy-Stuart","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.6545","article-title":"Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study","volume":"34","author":"Mostoufi-Moab","year":"2016","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior Hypopituitarism in Adult Survivors of Childhood Cancers Treated With Cranial Radiotherapy: A Report From the St Jude Lifetime Cohort Study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic\u2013pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<564::AID-MPO8>3.0.CO;2-N","article-title":"Dosimetry and Growth Hormone Deficiency Following Cranial Irradiation of Childhood Brain Tumors","volume":"33","author":"Schmiegelow","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb01260.x","article-title":"Radiation-Induced Hypopituitarism Is Dose-Dependent","volume":"31","author":"Littley MD","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-198906000-00001","article-title":"Growth and Endocrine Disorders Secondary to Cranial Irradiation","volume":"25","author":"Rappaport","year":"1989","journal-title":"Pediatr Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1750-3639.1997.tb01065.x","article-title":"Optic Chiasmatic-Hypothalamic Glioma","volume":"7","author":"Alshail","year":"1997","journal-title":"Brain Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.2.108","article-title":"Growth and Endocrine Sequelae of Craniopharyngioma","volume":"75","author":"DeVile","year":"1996","journal-title":"Arch Dis Child"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00330-1","article-title":"Intracranial Germinoma: The Case for Lower Dose Radiation Therapy","volume":"39","author":"Hardenbergh","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/adc.67.9.1107","article-title":"Endocrine Deficit After Fractionated Total Body Irradiation","volume":"67","author":"Ogilvy-Stuart","year":"1992","journal-title":"Arch Dis Child"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.4.458","article-title":"Growth and Growth Hormone Secretion After Bone Marrow Transplantation","volume":"68","author":"Brauner","year":"1993","journal-title":"Arch Dis Child"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24252","article-title":"Late Effects of Total Body Irradiation and Hematopoietic Stem Cell Transplant in Children Under 3 Years of Age","volume":"60","author":"Mulcahy Levy","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0022-3476(05)81537-9","article-title":"Final Height After Treatment for Childhood Acute Lymphoblastic Leukemia: Comparison of No Cranial Irradiation With 1800 and 2400 Centigrays of Cranial Irradiation","volume":"123","author":"Sklar","year":"1993","journal-title":"J Pediatr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00438.x","article-title":"Growth Hormone Status in Adults Treated for Acute Lymphoblastic Leukaemia in Childhood","volume":"48","author":"Brennan","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1988.tb10817.x","article-title":"Disturbed Pubertal Growth in Girls After Acute Leukaemia: A Relative Growth Hormone Insufficiency With Late Presentation","volume":"77","author":"Moell","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80989-0","article-title":"Reduced Pulsatile Growth Hormone Secretion in Children After Therapy for Acute Lymphoblastic Leukemia","volume":"104","author":"Blatt","year":"1984","journal-title":"J Pediatr"},{"key":"B55","article-title":"Reduced Hypothalamic Blood Flow After Radiation Treatment of Nasopharyngeal Cancer: SPECT Studies in 34 Patients","volume":"12","author":"Chieng","year":"1991","journal-title":"Am J Neuroradiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a068535","article-title":"Effects of Cranial Irradiation on Hypothalamic-Pituitary Function\u2014 a 5-Year Longitudinal Study in Patients With Nasopharyngeal Carcinoma","volume":"78","author":"Lam","year":"1991","journal-title":"Qjm"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1984.tb09908.x","article-title":"Incidence of Anterior Pituitary Deficiency After Radiotherapy at an Early Age: Study in Retinoblastoma","volume":"73","author":"Pomarede","year":"1984","journal-title":"Acta P\u00e6diatrica"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12773","article-title":"Growth Hormone Deficiency After Childhood Bone Marrow Transplantation With Total Body Irradiation: Interaction With Adiposity and Age","volume":"83","author":"Davis","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth Hormone Secretion After Conformal Radiation Therapy in Pediatric Patients With Localized Brain Tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J Clin Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.1055","article-title":"Aging and Risk of Severe, Disabling, Life-Threatening, and Fatal Events in the Childhood Cancer Survivor Study","volume":"32","author":"Armstrong","year":"2014","journal-title":"J Clin Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01226","article-title":"Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study","volume":"38","author":"Hayek","year":"2020","journal-title":"J Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.6585","article-title":"Occurrence of Multiple Subsequent Neoplasms in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study","volume":"29","author":"Armstrong","year":"2011","journal-title":"J Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab080","article-title":"Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER","volume":"106","author":"S\u00e4vendahl","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30163-7","article-title":"Long-Term Mortality After Childhood Growth Hormone Treatment: The SAGhE Cohort Study","volume":"8","author":"S\u00e4vendahl","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01133","article-title":"Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort","volume":"104","author":"Swerdlow","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01189","article-title":"Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program","volume":"104","author":"Child","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-0735","article-title":"Risk Factors of Subsequent Central Nervous System Tumors After Childhood and Adolescent Cancers: Findings From the French Childhood Cancer Survivor Study","volume":"30","author":"Journy","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0369","article-title":"Influence of Growth Hormone Therapy on the Occurrence of a Second Neoplasm in Survivors of Childhood Cancer","volume":"183","author":"Thomas-Teinturier","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0967","article-title":"Incidence of Second Neoplasm in Childhood Cancer Survivors Treated With GH: An Analysis of GeNeSIS and HypoCCS","volume":"168","author":"Woodmansee","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4159","article-title":"Growth Hormone Exposure as a Risk Factor for the Development of Subsequent Neoplasms of the Central Nervous System: A Report From the Childhood Cancer Survivor Study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0112","article-title":"Long-Term Safety of Growth Hormone Replacement After CNS Irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.7.8606","article-title":"Risk of Disease Recurrence and Second Neoplasms in Survivors of Childhood Cancer Treated With Growth Hormone: A Report From the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0656","article-title":"Growth Hormone Treatment and Risk of Second Neoplasms in the Childhood Cancer Survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1080\/08035250600577889","article-title":"Recurrence of Brain Tumours in Patients Treated With Growth Hormone: Analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-017-9966-x","article-title":"The GH\/IGF-1 Axis in a Critical Period Early in Life Determines Cellular DNA Repair Capacity by Altering Transcriptional Regulation of DNA Repair-Related Genes: Implications for the Developmental Origins of Cancer","volume":"39","author":"Podlutsky","year":"2017","journal-title":"GeroScience"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1985.02140060029020","article-title":"Growth Hormone Therapy and Tumor Recurrence: Findings in Children With Brain Neoplasms and Hypopituitarism","volume":"139","author":"Arslanian","year":"1985","journal-title":"Am J Dis Child"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6842.1601","article-title":"Growth Hormone and Tumour Recurrence","volume":"304","author":"Ogilvy-Stuart","year":"1992","journal-title":"Br Med J"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2010.150","article-title":"Growth Hormone Therapy and the Risk of Tumor Recurrence After Brain Tumor Treatment in Children","volume":"23","author":"Rohrer","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2014.04.016","article-title":"Growth Hormone Treatment and Risk of Recurrence or Development of Secondary Neoplasms in Survivors of Pediatric Brain Tumors","volume":"21","author":"Wang","year":"2014","journal-title":"J Clin Neurosci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.12.4444","article-title":"Growth Hormone Treatment of Children With Brain Tumors and Risk of Tumor Recurrence","volume":"85","author":"Swerdlow","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos208","article-title":"Ionizing Radiation and the Risk of Brain and Central Nervous System Tumors: A Systematic Review","volume":"14","author":"Braganza","year":"2012","journal-title":"Neuro Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.745932\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T07:08:51Z","timestamp":1634886531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.745932\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":82,"alternative-id":["10.3389\/fendo.2021.745932"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.745932","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"article-number":"745932"}}